Shepherd Kaplan Krochuk’s Impax Laboratories, Inc. IPXL Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,430	Closed	-$226K	–	464
2015 Q3	$226K	Sell	6,430 -2,036	-24%	-$91.7K	0.06%	234
2015 Q2	$389K	Sell	8,466 -2,081	-20%	-$98.8K	0.07%	202
2015 Q1	$494K	Sell	10,547 -1,394	-12%	-$55.5K	0.09%	177
2014 Q4	$378K	Hold	11,941	–	–	0.06%	247
2014 Q3	$283K	Buy	11,941 +1,010	+9%	+$25.9K	0.04%	332
2014 Q2	$328K	Hold	10,931	–	–	0.03%	309
2014 Q1	$289K	Hold	10,931	–	–	0.03%	331
2013 Q4	$275K	Hold	10,931	–	–	0.03%	355
2013 Q3	$224K	Hold	10,931	–	–	0.04%	413
2013 Q2	$218K	Buy	+10,931	New	+$194K	0.04%	404

Other funds holding IPXL

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Shepherd Kaplan Krochuk's IPXL Position: Q4 2015 in Review

Shepherd Kaplan Krochuk sold out of Impax Laboratories, Inc. (IPXL) in Q4 2015, closing a stake of 6,430 shares — an estimated $226K sold.

Shepherd Kaplan Krochuk first reported a position in IPXL in Q2 2013 and held it in 10 quarters. The position peaked at $494K in Q1 2015. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

Shepherd Kaplan Krochuk reported no remaining Impax Laboratories, Inc. position as of Q4 2015 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 6,430 Impax Laboratories, Inc. shares in Q4 2015, an estimated $226K.
Shepherd Kaplan Krochuk first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 10 quarters.
Shepherd Kaplan Krochuk's Impax Laboratories, Inc. position peaked at $494K in Q1 2015.
196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2015, filed 16 Feb 2016.